VC-02
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for VC-02, covering 2024-12-03 to 2024-12-03. Get the full timeline:
Most recent: Clinical Trial Update: A Safety, Tolerability, and Efficacy Study of VC-02™ Combination Product in Subjects With Type 1 Diabetes Mellitus and Hypoglycemia Unawareness [Phase 1, Phase 2]